Irfan, Muhammad and Akram, Waqar and James Hooper, Vincent (2020): What factors can help COVID-19 patients to recover quickly in Pakistan.
Preview |
PDF
MPRA_paper_103053.pdf Download (273kB) | Preview |
Abstract
The research paper uncovers the socioeconomic factors which are associated with the recovery of coronavirus in Pakistan. Using a self-designed questionnaire, we collected the data from 170 corona recovered patients and applied Multiple linear regression to predict the effect of socioeconomic factors. The paper finds that patients aged between 36 and 46 years take around 3 more days to recover, whereas, patients aged above than 46 years take around 7 more days to recover in comparison to the young adults (17-25 years). In addition, patients who live in urban areas recover almost 1.5 days earlier than those who live in rural areas. Patients who have other serious diseases take almost 1.7 more days to recover in comparison to those who do not have any disease. Patients who smoke take 2 more days to recover in comparison to those who do not smoke. Moreover, obese people take almost 2.6 more days to recover in comparison to those who have a normal body mass index. Surprisingly, income, gender, and education remain insignificant in relation to the recovery days. We suggest, people above 46 should be given extra care, policies regarding smoking cessation, and lowering obesity should be implemented to combat coronavirus.
Item Type: | MPRA Paper |
---|---|
Original Title: | What factors can help COVID-19 patients to recover quickly in Pakistan |
English Title: | What factors can help COVID-19 patients to recover quickly in Pakistan |
Language: | English |
Keywords: | COVID-19; Recovery; Factors; Pakistan |
Subjects: | I - Health, Education, and Welfare > I1 - Health > I12 - Health Behavior I - Health, Education, and Welfare > I1 - Health > I15 - Health and Economic Development I - Health, Education, and Welfare > I1 - Health > I18 - Government Policy ; Regulation ; Public Health |
Item ID: | 103053 |
Depositing User: | Dr Muhammad Irfan |
Date Deposited: | 05 Oct 2020 13:17 |
Last Modified: | 05 Oct 2020 13:17 |
References: | 1. Abid, K., Bari, Y. A., Younas, M., Tahir Javaid, S., & Imran, A. (2020). Progress of COVID-19 Epidemic in Pakistan. Asia-Pacific Journal of Public Health. https://doi.org/10.1177/1010539520927259 2. Alqahtani, J. S., Oyelade, T., Aldhahir, A. M., Alghamdi, S. M., Almehmadi, M., Alqahtani, A. S., Quaderi, S., Mandal, S., & Hurst, J. R. (2020). Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis. PLOS ONE, 15(5), e0233147. https://doi.org/10.1371/journal.pone.0233147 3. Ayyoubzadeh, S. M., Ayyoubzadeh, S. M., Zahedi, H., Ahmadi, M., & Kalhori, S. R. N. (2020). Predicting COVID-19 Incidence Through Analysis of Google Trends Data in Iran: Data Mining and Deep Learning Pilot Study. JMIR Public Health and Surveillance, 6(2), e18828. https://doi.org/10.2196/18828 4. Berlin, I., Thomas, D., Le Faou, A.-L., & Cornuz, J. (2020). COVID-19 and Smoking. Nicotine & Tobacco Research, 22(9), 1650–1652. https://doi.org/10.1093/ntr/ntaa059 5. Cai, Q., Chen, F., Wang, T., Luo, F., Liu, X., Wu, Q., He, Q., Wang, Z., Liu, Y., Liu, L., Chen, J., & Xu, L. (2020). Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China. Diabetes Care, 43(7), 1392–1398. https://doi.org/10.2337/dc20-0576 6. Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S. C., & Di Napoli, R. (2020). Features, Evaluation, and Treatment of Coronavirus (COVID-19). In StatPearls. StatPearls Publishing. http://www.ncbi.nlm.nih.gov/books/NBK554776/ 7. Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., Xia, J., Yu, T., Zhang, X., & Zhang, L. (2020). Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. The Lancet, 395(10223), 507–513. https://doi.org/10.1016/S0140-6736(20)30211-7 8. Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., Ma, K., Xu, D., Yu, H., Wang, H., Wang, T., Guo, W., Chen, J., Ding, C., Zhang, X., Huang, J., Han, M., Li, S., Luo, X., … Ning, Q. (2020). Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study. BMJ, 368. https://doi.org/10.1136/bmj.m1091 9. Coccia, M. (2020). Factors determining the diffusion of COVID-19 and suggested strategy to prevent future accelerated viral infectivity similar to COVID. Science of The Total Environment, 729, 138474. https://doi.org/10.1016/j.scitotenv.2020.138474 10. Evans, O. (2020). Socio-economic impacts of novel coronavirus: The policy solutions. BizEcons Quarterly, 7, 3–12. 11. Farsalinos, K., Barbouni, A., & Niaura, R. (2020). Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: Could nicotine be a therapeutic option? Internal and Emergency Medicine, 15(5), 845–852. https://doi.org/10.1007/s11739-020-02355-7 12. Farsalinos, K., Barbouni, A., Poulas, K., Polosa, R., Caponnetto, P., & Niaura, R. (2020). Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: A systematic review and meta-analysis. Therapeutic Advances in Chronic Disease, 11, 2040622320935765. https://doi.org/10.1177/2040622320935765 13. Harapan, H., Itoh, N., Yufika, A., Winardi, W., Keam, S., Te, H., Megawati, D., Hayati, Z., Wagner, A. L., & Mudatsir, M. (2020). Coronavirus disease 2019 (COVID-19): A literature review. Journal of Infection and Public Health, 13(5), 667–673. https://doi.org/10.1016/j.jiph.2020.03.019 14. Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., Cheng, Z., Yu, T., Xia, J., Wei, Y., Wu, W., Xie, X., Yin, W., Li, H., Liu, M., … Cao, B. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, 395(10223), 497–506. https://doi.org/10.1016/S0140-6736(20)30183-5 15. Jin, J.-M., Bai, P., He, W., Wu, F., Liu, X.-F., Han, D.-M., Liu, S., & Yang, J.-K. (2020). Gender Differences in Patients With COVID-19: Focus on Severity and Mortality. Frontiers in Public Health, 8. https://doi.org/10.3389/fpubh.2020.00152 16. Kass, D. A., Duggal, P., & Cingolani, O. (2020). Obesity could shift severe COVID-19 disease to younger ages. Lancet (London, England), 395(10236), 1544–1545. https://doi.org/10.1016/S0140-6736(20)31024-2 Lu, H., Stratton, C. W., & Tang, Y.-W. (2020). Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. Journal of Medical Virology, 92(4), 401–402. https://doi.org/10.1002/jmv.25678 17. Stefan, N., Birkenfeld, A. L., Schulze, M. B., & Ludwig, D. S. (2020). Obesity and impaired metabolic health in patients with COVID-19. Nature Reviews Endocrinology, 16(7), 341–342. https://doi.org/10.1038/s41574-020-0364-6 18. Stojkoski, V., Utkovski, Z., Jolakoski, P., Tevdovski, D., & Kocarev, L. (2020). The socio-economic determinants of the coronavirus disease (COVID-19) pandemic. ArXiv:2004.07947 [Physics, q-Fin, Stat]. http://arxiv.org/abs/2004.07947 19. Xiong, Y., Sun, D., Liu, Y., Fan, Y., Zhao, L., Li, X., & Zhu, W. (2020). Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes. Investigative Radiology. https://doi.org/10.1097/RLI.0000000000000674 |
URI: | https://mpra.ub.uni-muenchen.de/id/eprint/103053 |